Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2025 08:00 ET | Source: Evaxion Biotech

Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package

Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data The additional third year of EVX-01 dosing may provide further...